Clinical Trial Update: Beneficial Side Effects of Topiramate in Obese Patients Undergoing Total Joint Arthroplasty [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating topiramate for weight loss in obese patients undergoing total joint arthroplasty has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Postoperative Pain

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: Stanford University | Conditions: Weight Loss, Pain, Postoperative | EARLY_Phase 1 | Status: WITHDRAWN